Clinical Trial Update: A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update reporting results from multiple immunotherapy-based treatment combinations in participants with metastatic pancreatic ductal ade…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Pancreatic Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-11-21